New study monitors BRCA carriers for early cancer signs
NCT ID NCT03296826
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 600 Japanese women who carry BRCA1 or BRCA2 gene changes to see how often they develop ovarian, fallopian tube, or peritoneal cancers. Participants are monitored over time, and researchers also check tissue samples from those who choose preventive surgery. The goal is to better understand cancer risks in this specific group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 AND/OR BRCA2 VARIANT CARRIERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Okayama University
RECRUITINGOkayama, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can engineered immune cells target a common ovarian cancer protein?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Experimental pill takes on Hard-to-Treat ovarian cancer
- Radioactive antibody targets rare childhood cancer
- Radiation boost may Re-Sensitize ovarian cancer to PARP inhibitors
- New PET tracer could spot cancers that standard scans overlook